{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:19:25Z","timestamp":1789215565160,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier","isbn-type":[{"value":"9780443194009","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.vh.2023.05.001","type":"book-chapter","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T10:34:28Z","timestamp":1685615668000},"page":"393-404","source":"Crossref","is-referenced-by-count":3,"title":["Angiotensin II-dependent aldosterone production in the adrenal cortex"],"prefix":"10.1016","author":[{"given":"Anastasios","family":"Lymperopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana I.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malka S.","family":"Suster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-12-381296-4.00002-6","article-title":"Assessment of inverse agonism for the angiotensin II type 1 receptor","volume":"485","author":"Akazawa","year":"2010","journal-title":"Methods in Enzymology"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ecl.2005.01.002","article-title":"Adrenal corticosteroid biosynthesis, metabolism, and action","volume":"34","author":"Arlt","year":"2005","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/bs.vh.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/JME-14-0125","article-title":"Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor","volume":"53","author":"Balakumar","year":"2014","journal-title":"Journal of Molecular Endocrinology"},{"issue":"20","key":"10.1016\/bs.vh.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1113\/JP271896","article-title":"Role of voltage-gated calcium channels in the regulation of aldosterone production from zona glomerulosa cells of the adrenal cortex","volume":"594","author":"Barrett","year":"2016","journal-title":"Journal of Physiology"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.113.02043","article-title":"Negative impact of \u03b2-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms","volume":"63","author":"Bathgate-Siryk","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2200345","article-title":"Inositol trisphosphate and diacylglycerol as second messengers","volume":"220","author":"Berridge","year":"1984","journal-title":"The Biochemical Journal"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cphy.c130037","article-title":"Regulation of aldosterone synthesis and secretion","volume":"4","author":"Bollag","year":"2014","journal-title":"Comprehensive Physiology"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/FJC.0000000000001213","article-title":"Adrenal G protein-coupled receptors and the failing heart: A long-distance, yet intimate affair","volume":"80","author":"Borges","year":"2022","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/07435809609043718","article-title":"Angiotensin II receptors in the human adrenal gland","volume":"22","author":"Breault","year":"1996","journal-title":"Endocrine Research"},{"issue":"Pt B","key":"10.1016\/bs.vh.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2015.05.019","article-title":"GPCR signaling and cardiac function","volume":"763","author":"Capote","year":"2015","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.vh.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.cellbio.22.010305.104656","article-title":"Cholesterol sensing, trafficking, and esterification","volume":"22","author":"Chang","year":"2006","journal-title":"Annual Review of Cell and Developmental Biology"},{"issue":"11","key":"10.1016\/bs.vh.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1210\/en.2003-0325","article-title":"Angiotensin II activates cholesterol ester hydrolase in bovine adrenal glomerulosa cells through phosphorylation mediated by p42\/p44 mitogen-activated protein kinase","volume":"144","author":"Cherradi","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal \u03b2arrestin1-dependent aldosterone production by ARBs: Head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib14","first-page":"415","article-title":"International Union of Pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.vh.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2018.02.007","article-title":"Biased Agonism\/Antagonism of cardiovascular GPCRs for heart failure therapy","volume":"339","author":"Desimine","year":"2018","journal-title":"International Review of Cell and Molecular Biology"},{"key":"10.1016\/bs.vh.2023.05.001_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109967","article-title":"Adrenal angiotensin II type 1 receptor biased signaling: The case for \u201cbiased\u201d inverse agonism for effective aldosterone suppression","volume":"82","author":"Ferraino","year":"2021","journal-title":"Cellular Signaling"},{"issue":"10","key":"10.1016\/bs.vh.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/hr.2010.135","article-title":"A small difference in the molecular structure of angiotensin II receptor blockers induces AT\u2081 receptor-dependent and -independent beneficial effects","volume":"33","author":"Fujino","year":"2010","journal-title":"Hypertension Research"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"37","key":"10.1016\/bs.vh.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"34888","DOI":"10.1074\/jbc.M102063200","article-title":"ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene","volume":"276","author":"Gyles","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"1\u20133","key":"10.1016\/bs.vh.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2008.05.010","article-title":"The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1\/2 activation and cellular proliferation","volume":"590","author":"Hansen","year":"2008","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cll.2004.01.004","article-title":"Steroid hormones: Relevance and measurement in the clinical laboratory","volume":"24","author":"Holst","year":"2004","journal-title":"Clinics in Laboratory Medicine"},{"issue":"17","key":"10.1016\/bs.vh.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.2174\/1381612811319170005","article-title":"Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers","volume":"19","author":"Imaizumi","year":"2013","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/pr.114.010454","article-title":"International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin receptors: Interpreters of pathophysiological angiotensinergic stimuli [corrected]","volume":"67","author":"Karnik","year":"2015","journal-title":"Pharmacological Reviews"},{"issue":"5","key":"10.1016\/bs.vh.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4103\/0253-7613.84947","article-title":"Inverse agonism and its therapeutic significance","volume":"43","author":"Khilnani","year":"2011","journal-title":"Indian Journal of Pharmacology"},{"key":"10.1016\/bs.vh.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1038\/ncomms14335","article-title":"Arrestin-biased GPCR agonism induces acute catecholamine secretion through TRPC3 coupling","volume":"8","author":"Liu","year":"2017","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/pr.109.002436","article-title":"Beyond desensitization: Physiological relevance of arrestin-dependent signaling","volume":"62","author":"Luttrell","year":"2010","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4330\/wjc.v9.i3.200","article-title":"Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy","volume":"9","author":"Lymperopoulos","year":"2017","journal-title":"World Journal of Cardiology"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm1553","article-title":"Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure","volume":"13","author":"Lymperopoulos","year":"2007","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2010.08.635","article-title":"Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels","volume":"57","author":"Lymperopoulos","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"10.1016\/bs.vh.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United Stated of America"},{"issue":"25","key":"10.1016\/bs.vh.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jacc.2014.09.070","article-title":"Different potencies of angiotensin receptor blockers at suppressing adrenal \u03b2-Arrestin1-dependent post-myocardial infarction hyperaldosteronism","volume":"64","author":"Lymperopoulos","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4330\/wjc.v11.i2.47","article-title":"Not all arrestins are created equal: Therapeutic implications of the functional diversity of the \u03b2-arrestins in the heart","volume":"11","author":"Lymperopoulos","year":"2019","journal-title":"World Journal of Cardiology"},{"key":"10.1016\/bs.vh.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.pmbts.2018.07.003","article-title":"Arrestins in the cardiovascular system: An update","volume":"159","author":"Lymperopoulos","year":"2018","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"Pt A","key":"10.1016\/bs.vh.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2017.05.009","article-title":"Biased agonism\/antagonism at the AngII-AT1 receptor: Implications for adrenal aldosterone production and cardiovascular therapy","volume":"125","author":"Maning","year":"2017","journal-title":"Pharmacological Research"},{"key":"10.1016\/bs.vh.2023.05.001_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719868134","article-title":"The place of ARBs in heart failure therapy: Is aldosterone suppression the key?","volume":"13","author":"Markan","year":"2019","journal-title":"Therapeutic Advances in Cardiovascular Disease"},{"key":"10.1016\/bs.vh.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ar.1091440407","article-title":"Arterial supply of the suprarenal gland","volume":"144","author":"Merklin","year":"1962","journal-title":"The Anatomical Record"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.vh.2023.05.001_bib38","first-page":"106","article-title":"Adrenal mitochondria and steroidogenesis: From individual proteins to functional protein assemblies","volume":"7","author":"Midzak","year":"2016","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"28","key":"10.1016\/bs.vh.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"19288","DOI":"10.1074\/jbc.M602144200","article-title":"Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor","volume":"281","author":"Miura","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320310370852","article-title":"Angiotensin II type 1 receptor blockers: class effects versus molecular effects","volume":"12","author":"Miura","year":"2011","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"issue":"6","key":"10.1016\/bs.vh.2023.05.001_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037974","article-title":"Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor","volume":"7","author":"Miura","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.001_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/me.2007-0312","article-title":"Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state","volume":"22","author":"Miura","year":"2008","journal-title":"Molecular Endocrinology"},{"issue":"5812","key":"10.1016\/bs.vh.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.1134562","article-title":"Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins","volume":"315","author":"Nelson","year":"2007","journal-title":"Science (New York, N. Y.)"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.001_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1254\/jphs.10R03FM","article-title":"New approaches to blockade of the renin-angiotensin-aldosterone system: Overview of regulation of the renin-angiotensin-aldosterone system","volume":"113","author":"Nishiyama","year":"2010","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.001_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2174\/1381612826666200115092015","article-title":"Emerging role of angiotensin AT2 receptor in anti-inflammation: An update","volume":"26","author":"Patel","year":"2020","journal-title":"Current Pharmaceutical Design"},{"issue":"6","key":"10.1016\/bs.vh.2023.05.001_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocrine Reviews"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2023.05.001_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2008.10.009","article-title":"Hormonal activation of a kinase cascade localized at the mitochondria is required for StAR protein activity","volume":"300","author":"Poderoso","year":"2009","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/ijms21020574","article-title":"GRK2-mediated crosstalk between \u03b2-adrenergic and angiotensin II receptors enhances adrenocortical aldosterone production in vitro and in vivo","volume":"21","author":"Pollard","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1\u20132","key":"10.1016\/bs.vh.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2003.12.020","article-title":"Adrenocortical cell lines","volume":"228","author":"Rainey","year":"2004","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"5","key":"10.1016\/bs.vh.2023.05.001_bib50","first-page":"649","article-title":"Diacylglycerol production, Ca2+ influx, and protein kinase C activation in sustained cellular responses","volume":"16","author":"Rasmussen","year":"1995","journal-title":"Endocrine Reviews"},{"issue":"31","key":"10.1016\/bs.vh.2023.05.001_bib51","doi-asserted-by":"crossref","first-page":"23911","DOI":"10.1074\/jbc.M001553200","article-title":"The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras","volume":"275","author":"Rizzo","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2023.05.001_bib52","first-page":"1209","article-title":"Current and future G protein-coupled receptor signaling targets for heart failure therapy","volume":"7","author":"Siryk-Bathgate","year":"2013","journal-title":"Drug Design, Development and Therapy"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: A model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiological Reviews"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.001_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1677\/joe.0.1640247","article-title":"The role of the StAR protein in steroidogenesis: Challenges for the future","volume":"164","author":"Stocco","year":"2000","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2023.05.001_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2017.06.013","article-title":"Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism","volume":"123","author":"Takezako","year":"2017","journal-title":"Pharmacological Research"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beem.2018.02.003","article-title":"Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk","volume":"32","author":"T\u00f3th","year":"2018","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2023.05.001_bib57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fendo.2019.00519","article-title":"The role of \u03b2-arrestin proteins in organization of signaling and regulation of the AT1 angiotensin receptor","volume":"10","author":"Turu","year":"2019","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.226","article-title":"Structure-activity relationship study of angiotensin II analogs in terms of \u03b2-arrestin-dependent signaling to aldosterone production","volume":"4","author":"Valero","year":"2016","journal-title":"Pharmacology Research and Perspectives"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.001_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.mce.2008.06.006","article-title":"Sartan-AT1 receptor interactions: In vitro evidence for insurmountable antagonism and inverse agonism","volume":"302","author":"Van Liefde","year":"2009","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"7650","key":"10.1016\/bs.vh.2023.05.001_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature22035","article-title":"Structural basis for selectivity and diversity in angiotensin II receptors","volume":"544","author":"Zhang","year":"2017","journal-title":"Nature"}],"container-title":["Vitamins and Hormones","Adrenal Gland"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672923000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672923000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T08:58:38Z","timestamp":1708765118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672923000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443194009"],"references-count":60,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2023.05.001","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}